• Western blot analysis of lysates from Jurkat cells treated with Insulin 0.01U/ml 15', using Calmodulin (Phospho-Thr79+Ser81) Antibody. The lane on the right is blocked with the phospho peptide.
  • Immunofluorescence analysis of HepG2 cells, using Calmodulin (Phospho-Thr79+Ser81) Antibody. The picture on the right is blocked with the phospho peptide.
  • Immunohistochemistry analysis of paraffin-embedded human brain, using Calmodulin (Phospho-Thr79+Ser81) Antibody. The picture on the right is blocked with the phospho peptide.
  • Western blot analysis of various cells using Phospho-Calmodulin (T80/S82) Polyclonal Antibody

Anti-Phospho-Calmodulin-Thr80/S82 antibody (46-95 aa) (STJ91072)

SKU:
STJ91072

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Phospho-Calmodulin-Thr80/S82 (46-95 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
IF 1:200-1:1000
ELISA 1:5000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Immunogen Region: 46-95 aa
Specificity: Phospho-Calmodulin (T80/S82) Polyclonal Antibody detects endogenous levels of Calmodulin protein only when phosphorylated at T80/S82.
Immunogen: The antiserum was produced against synthesized peptide derived from the human Calmodulin around the phosphorylation site of Thr79 and Ser81 at the amino acid range 46-95
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance